| Health / Medical Topics |
Cabozantinib
An orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET), RET (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression. (NCI Thesaurus)
YOU MAY ALSO LIKE
The determination of the number of Cabot rings present in a sample.
A drug used to treat advanced renal cell carcinoma (a type of kidney cancer) that was treated with antiangiogenesis therapy (a type…
A regimen consisting of cisplatin, methotrexate, bleomycin and vincristine used for the treatment of unresectable and recurrent head and neck squamous cell…
A long, thin, multistranded rope or rope-like object; a multistranded conductor designed to carry signals over a distance.
A globally unique identifier deployed by systems that are compatible with the caGrid.
A synthetic ergoline derivative and a long-acting dopamine receptor agonist with high affinity for the dopamine D2 receptor. Cabergoline exerts an inhibitory…
